-+ 0.00%
-+ 0.00%
-+ 0.00%
Why Sportradar Group (SRAD) Is Up 6.9% After Q2 Loss and Major Buyback Shift
Share
Listen to the news
  • Sportradar Group AG recently reported its second-quarter 2026 results, with sales rising to €377.82 million from €317.79 million a year earlier, but moving from net income of €49.25 million to a net loss of €3.52 million.
  • For the first half of 2026, revenue increased to €724.33 million from €629.02 million, yet the company recorded a €9.8 million net loss versus €73.45 million net income previously, while also completing a US$422.32 million buyback of 26,000,000 shares, equal to 8.65% of its share count.
  • With revenue growth but a shift to losses now on the table, we'll examine how this earnings profile affects Sportradar's investment narrative.

Invest in the nuclear renaissance through our list of 91 elite nuclear energy infrastructure plays powering the global AI revolution.

Sportradar Group Investment Narrative Recap

To own Sportradar, you need to believe that growing global demand for real time sports data and betting services can outweigh rising costs and competitive pressure. The latest results show revenue still increasing but profitability slipping into losses, which makes margin resilience the key short term catalyst and puts cost discipline and contract quality in sharper focus. This earnings shift highlights margin compression risk but does not fundamentally alter the long term data and rights driven thesis.

The most relevant recent announcement here is the completion of the US$422.32 million buyback, retiring 26,000,000 shares or 8.65% of the share count. Against a move from profit to loss, such a large capital return puts more emphasis on future cash generation and rights spending, especially if sports rights or technology investments continue to rise, and it sits directly alongside the margin and competition related catalysts investors are watching.

Yet beneath the headline revenue growth, investors should be aware that...

Read the full narrative on Sportradar Group (it's free!)

Sportradar Group's narrative projects €2.0 billion revenue and €242.0 million earnings by 2029. This requires 13.0% yearly revenue growth and about a €225 million earnings increase from €17.1 million today.

Uncover how Sportradar Group's forecasts yield a $18.50 fair value, a 36% upside to its current price.

Exploring Other Perspectives

SRAD 1-Year Stock Price Chart
SRAD 1-Year Stock Price Chart

Compared with the consensus story, the lowest analysts already assumed about €2.0 billion revenue and €245.9 million earnings by 2029, yet they see prediction market regulation and legal overhang as reasons this more cautious path could still be too optimistic after results like these.

Explore 3 other fair value estimates on Sportradar Group - why the stock might be worth just $18.50!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

Looking For Alternative Opportunities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending